Tempest Therapeutics, Inc.
Data quality: 83%
TPST
Nasdaq
Manufacturing
Chemicals
$1.56
$0.00
(0.00%)
Mkt Cap: 22.38 M
Price
$1.56
Mkt Cap
22.38 M
Day Range
$1.55 — $1.63
52-Week Range
$1.50 — $12.23
Volume
104,419
Open $1.56
50D / 200D Avg
$2.26
31.00% below
50D / 200D Avg
$6.08
74.34% below
Quick Summary
Key Takeaways
Negative free cash flow of -26.82 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-325.65%
Below sector avg (-53.47%)
ROIC-135.68%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio2.30
Interest Coverage-128.38
Valuation
PE (TTM)
-0.85
Above sector avg (-1.47)
P/B Ratio3.53
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.9 | -1.5 |
| P/B | 3.5 | 1.6 |
| ROE % | -325.7 | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -26.26 M |
| ROE | -325.65% | ROA | -126.22% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -26.82 M |
| ROIC | -135.68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.30 |
| Interest Coverage | -128.38 | Asset Turnover | N/A |
| Working Capital | 4.58 M | Tangible Book Value | 6.35 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.85 | Forward P/E | N/A |
| P/B Ratio | 3.53 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -119.86% | ||
| Market Cap | 22.38 M | Enterprise Value | 14.86 M |
| Per Share | |||
| EPS (Diluted TTM) | -6.33 | Revenue / Share | N/A |
| FCF / Share | -1.87 | OCF / Share | -1.87 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 102.12% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -26.26 M | -41.84 M | -29.49 M | -35.71 M | -28.30 M |
| EPS (Diluted) | -6.33 | -1.50 | -1.91 | -3.09 | -7.47 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -26.58 M | -42.03 M | -29.16 M | -34.64 M | -26.99 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 207,000.0 | 1.32 M | 1.45 M | 1.62 M | 1.28 M |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 16.93 M | 41.49 M | 51.60 M | 46.09 M | 73.24 M |
| Total Liabilities | 10.26 M | 22.36 M | 24.84 M | 27.98 M | 37.12 M |
| Shareholders' Equity | 6.67 M | 19.13 M | 26.77 M | 18.11 M | 36.12 M |
| Total Debt | — | 6.40 M | 10.50 M | 10.40 M | 15.07 M |
| Cash & Equivalents | 7.71 M | 30.27 M | 39.23 M | 31.23 M | 51.83 M |
| Current Assets | 8.27 M | 31.47 M | 40.36 M | 32.95 M | 68.96 M |
| Current Liabilities | 3.31 M | 14.22 M | 9.41 M | 7.28 M | 20.03 M |
{"event":"ticker_viewed","properties":{"ticker":"TPST","listing_kind":"stock","pathname":"/stocks/tpst","exchange":"Nasdaq","country":"US"}}